Browsing byAuthorHaghi, M

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 31  next >
Issue DateTitleAuthor(s)
2014-01-01Across the pulmonary epithelial barrier: Integration of physicochemical properties and human cell models to study pulmonary drug formulationsHaghi, M; Ong, HX; Traini, D; Young, P
2016-02-15Antibiotic transport across bronchial epithelial cells: Effects of molecular weight, LogP and apparent permeabilityStigliani, M; Haghi, M; Russo, P; Young, PM; Traini, D
2019-05-01Autophagy activation in asthma airways remodelingMcAlinden, KD; Deshpande, DA; Ghavami, S; Xenaki, D; Sohal, SS; Oliver, BG; Haghi, M; Sharma, P
2018-06-11Autophagy and airway fibrosis: Is there a link?Kota, A; Deshpande, D; Haghi, M; Oliver, B; Sharma, P
2017-01-01Autophagy and airway fibrosis: Is there a link?Sharma, P; Kota, A; Deshpande, D; Haghi, M; Oliver, B
2018-01-01Autophagy Is Selectively Activated and Correlated with Airway Remodeling in AsthmaMcAlinden, K; Oliver, B; Haghi, M; Sharma, P
2010-01Characterization of P-gp Expression and Function vs. Time and Passage in the Calu-3 Air-Interface Model for Drug Delivery to the LungHaghi, M; Young, P; Traini, D; Bebawy, M; Dalby, RN; Byron, PR; Peart, J; Suman, JD; Farr, SJ; Young, PM
2011-01Comparison of albuterol sulphate and base dry powder particulate deposition using the Calu-3 lung epithelial modelHaghi, M; Traini, D; Bebawy, M; Young, P; Dalby, RN; Byron, PR; Peart, J; Suman, JD; Young, PM
2012-06-04Deposition, diffusion and transport mechanism of dry powder microparticulate salbutamol, at the respiratory epitheliaHaghi, M; Traini, D; Bebawy, M; Young, PM
2015-06-01Development of an inhaled controlled release voriconazole dry powder formulation for the treatment of respiratory fungal infectionArora, S; Haghi, M; Loo, CY; Traini, D; Young, PM; Jain, S
2014Effect of Particle Size and Excipients on the Uptake of Beclomethasone Dipropionate-Pressurized Metered Dose Inhalers After Deposition on Calu-3 Respiratory EpitheliaHaghi, M; Traini, D; Lewis, DA; Forbes, B; Colombo, P; Young, PM; Dalby RN, Byron PR, Peart J, Suman JD, Young PM, Traini D
2018-03-01EXPRESSION OF AUTOPHAGY MARKERS IN THE HUMAN ASTHMATIC EPITHELIUMMcalinden, K; Oliver, B; Haghi, M; Sharma, P
2013-11-01Fluticasone uptake across Calu-3 cells is mediated by salmeterol when deposited as a combination powder inhalerHaghi, M; Traini, D; Postma, DS; Bebawy, M; Young, PM
2015-05-05The formulation of a pressurized metered dose inhaler containing theophylline for inhalationZhu, B; Haghi, M; Goud, M; Young, PM; Traini, D
2014-01-01The formulation, chemical and physical characterisation of clarithromycin-based macrolide solution pressurised metered dose inhalerSaadat, A; Zhu, B; Haghi, M; King, G; Colombo, G; Young, PM; Traini, D
2015-07-03In vitro biological activity of resveratrol using a novel inhalable resveratrol spray-dried formulationTrotta, V; Lee, WH; Loo, CY; Haghi, M; Young, PM; Scalia, S; Traini, D
2015-05-26Inhalable tranexamic acid for haemoptysis treatmentHaghi, M; Van Den Oetelaar, W; Moir, LM; Zhu, B; Phillips, G; Crapper, J; Young, PM; Traini, D
2014-01-01An Investigation Into Salbutamol Sulfate Dry Powder Transport Across Calu-3 And Differentiated Human Bronchial Epithelial CellsZeng, QX; Haghi, M; Rimmer, J; Black, J; Shi, J; Oliver, BG; Ge, Q
2016-01-01An investigation of surface properties, local elastic modulus and interaction with simulated pulmonary surfactant of surface modified inhalable voriconazole dry powders using atomic force microscopyArora, S; Kappl, M; Haghi, M; Young, PM; Traini, D; Jain, S
2018-03-01LIPOSOMAL FORMULATION OF QUERCETIN AND RESOLVIND1 FOR TREATMENT OF STEROID RESISTANT AIRWAY INFLAMMATIONKomalla, V; Mcalinden, K; Ramaccini, D; Scalia, S; Sharma, P; Oliver, B; Haghi, M